Eculizumab in the treatment of atypical hemolytic uremic syndrome in an infant leads to cessation of peritoneal dialysis and improvement of severe hypertension.
about
Critical appraisal of eculizumab for atypical hemolytic uremic syndromeNeonatal atypical hemolytic uremic syndrome from a factor H mutation treated with eculizumabAtypical hemolytic uremic syndrome in the setting of complement-amplifying conditions: case reports and a review of the evidence for treatment with eculizumab.Timing of eculizumab therapy for C3 glomerulonephritis.Hypertensive Crisis and Refractory Hypertension Caused by Atypical Hemolytic Uremic Syndrome and Effect of Eculizumab
P2860
Eculizumab in the treatment of atypical hemolytic uremic syndrome in an infant leads to cessation of peritoneal dialysis and improvement of severe hypertension.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Eculizumab in the treatment of ...... vement of severe hypertension.
@ast
Eculizumab in the treatment of ...... vement of severe hypertension.
@en
type
label
Eculizumab in the treatment of ...... vement of severe hypertension.
@ast
Eculizumab in the treatment of ...... vement of severe hypertension.
@en
prefLabel
Eculizumab in the treatment of ...... vement of severe hypertension.
@ast
Eculizumab in the treatment of ...... vement of severe hypertension.
@en
P2093
P2860
P1433
P1476
Eculizumab in the treatment of ...... vement of severe hypertension.
@en
P2093
Hiroaki Ono
Kazuhiko Jinno
Keita Matsubara
Kohtaro Urayama
Sayaka Imai
Takashi Sakano
Takeki Furue
Toshiyuki Miyata
Toshiyuki Ohta
Yoko Yoshida
P2860
P2888
P304
P356
10.1007/S00467-014-2975-4
P577
2014-10-16T00:00:00Z
P5875
P6179
1052362852